Literature DB >> 21296237

Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial.

Lidy M Pelsser1, Klaas Frankena, Jan Toorman, Huub F Savelkoul, Anthony E Dubois, Rob Rodrigues Pereira, Ton A Haagen, Nanda N Rommelse, Jan K Buitelaar.   

Abstract

BACKGROUND: The effects of a restricted elimination diet in children with attention-deficit hyperactivity disorder (ADHD) have mainly been investigated in selected subgroups of patients. We aimed to investigate whether there is a connection between diet and behaviour in an unselected group of children.
METHODS: The Impact of Nutrition on Children with ADHD (INCA) study was a randomised controlled trial that consisted of an open-label phase with masked measurements followed by a double-blind crossover phase. Patients in the Netherlands and Belgium were enrolled via announcements in medical health centres and through media announcements. Randomisation in both phases was individually done by random sampling. In the open-label phase (first phase), children aged 4-8 years who were diagnosed with ADHD were randomly assigned to 5 weeks of a restricted elimination diet (diet group) or to instructions for a healthy diet (control group). Thereafter, the clinical responders (those with an improvement of at least 40% on the ADHD rating scale [ARS]) from the diet group proceeded with a 4-week double-blind crossover food challenge phase (second phase), in which high-IgG or low-IgG foods (classified on the basis of every child's individual IgG blood test results) were added to the diet. During the first phase, only the assessing paediatrician was masked to group allocation. During the second phase (challenge phase), all persons involved were masked to challenge allocation. Primary endpoints were the change in ARS score between baseline and the end of the first phase (masked paediatrician) and between the end of the first phase and the second phase (double-blind), and the abbreviated Conners' scale (ACS) score (unmasked) between the same timepoints. Secondary endpoints included food-specific IgG levels at baseline related to the behaviour of the diet group responders after IgG-based food challenges. The primary analyses were intention to treat for the first phase and per protocol for the second phase. INCA is registered as an International Standard Randomised Controlled Trial, number ISRCTN 76063113.
FINDINGS: Between Nov 4, 2008, and Sept 29, 2009, 100 children were enrolled and randomly assigned to the control group (n=50) or the diet group (n=50). Between baseline and the end of the first phase, the difference between the diet group and the control group in the mean ARS total score was 23·7 (95% CI 18·6-28·8; p<0·0001) according to the masked ratings. The difference between groups in the mean ACS score between the same timepoints was 11·8 (95% CI 9·2-14·5; p<0·0001). The ARS total score increased in clinical responders after the challenge by 20·8 (95% CI 14·3-27·3; p<0·0001) and the ACS score increased by 11·6 (7·7-15·4; p<0·0001). In the challenge phase, after challenges with either high-IgG or low-IgG foods, relapse of ADHD symptoms occurred in 19 of 30 (63%) children, independent of the IgG blood levels. There were no harms or adverse events reported in both phases.
INTERPRETATION: A strictly supervised restricted elimination diet is a valuable instrument to assess whether ADHD is induced by food. The prescription of diets on the basis of IgG blood tests should be discouraged. FUNDING: Foundation of Child and Behaviour, Foundation Nuts Ohra, Foundation for Children's Welfare Stamps Netherlands, and the KF Hein Foundation.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21296237     DOI: 10.1016/S0140-6736(10)62227-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  44 in total

1.  Chemical intolerance in primary care settings: prevalence, comorbidity, and outcomes.

Authors:  David A Katerndahl; Iris R Bell; Raymond F Palmer; Claudia S Miller
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

2.  Food, mood, and brain health: implications for the modern clinician.

Authors:  Laura Lachance; Drew Ramsey
Journal:  Mo Med       Date:  2015 Mar-Apr

Review 3.  Food insecurity and hunger: A review of the effects on children's health and behaviour.

Authors:  Janice Ke; Elizabeth Lee Ford-Jones
Journal:  Paediatr Child Health       Date:  2015-03       Impact factor: 2.253

4.  Is there a future for restricted elimination diets in ADHD clinical practice?

Authors:  Nanda Rommelse; Jan Buitelaar
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-04       Impact factor: 4.785

Review 5.  Developmental context and treatment principles for ADHD among college students.

Authors:  Andrew P Fleming; Robert J McMahon
Journal:  Clin Child Fam Psychol Rev       Date:  2012-12

6.  The effect of dietary approaches to stop hypertension (DASH) diet on attention-deficit hyperactivity disorder (ADHD) symptoms: a randomized controlled clinical trial.

Authors:  Yadollah Khoshbakht; Fatemeh Moghtaderi; Reza Bidaki; Mahdieh Hosseinzadeh; Amin Salehi-Abargouei
Journal:  Eur J Nutr       Date:  2021-03-14       Impact factor: 5.614

7.  Editorial focused issue 'The role of nutrition in child and adolescent onset mental disorders'.

Authors:  Nanda Lambregts-Rommelse; Johannes Hebebrand
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-09       Impact factor: 4.785

Review 8.  Gut microbiota and attention deficit hyperactivity disorder: new perspectives for a challenging condition.

Authors:  María Carmen Cenit; Isabel Campillo Nuevo; Pilar Codoñer-Franch; Timothy G Dinan; Yolanda Sanz
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-03-13       Impact factor: 4.785

9.  Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers : is it justified?

Authors:  Jaswinder K Ghuman; Harinder S Ghuman
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

10.  Oxidative stress and immune aberrancies in attention-deficit/hyperactivity disorder (ADHD): a case-control comparison.

Authors:  Annelies A J Verlaet; Annelies Breynaert; Berten Ceulemans; Tess De Bruyne; Erik Fransen; Luc Pieters; Huub F J Savelkoul; Nina Hermans
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-10-22       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.